Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients. Telix has positively engaged with the FDA on a New Drug Application (NDA) pathway in the U.S. that...
AegisClear Aligns Strategy with Taiwan's Asian Asset Management Center Initiative
Developing Digital Asset Infrastructure to Support Financial Innovation and Cross-Border Connectivity KAOHSIUNG, Aug. 5, 2026 /PRNewswire/ -- AegisClear, a Taiwan-based digital asset technology platform, today announced its commitment to expand its...
Super Sourcing Platform Connexion Shenzhen Aligns with Canton Fair in October, Creating Ultimate Buyer Journey.
Comprehensive Service Upgrades Enable Efficient Dual-City Sourcing Experience for Global Procurement Professionals SHENZHEN, China, May 26, 2026 /PRNewswire/ -- Connexion ShenZhen 2026, organized by Shanghai Sinoexpo Informa Markets International...